5Mcintosh K. Community-acquired pneumonia in children. N Engl J Med, 2002,346 (6) :429.
6Waterer GW,Somes GW,Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Inter Med,2001,161:1837-1842.
7Niederman MS,Mandell LA,Anzueto A,et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis,assessment of severity,antimicrobial thereapy,and prevention. Am J Respir Crit Care Med,2001,163:1730-1754.
8Ichimiya T,Yamsaki T,Nasu M. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother,1994,34:331-341.
9World Health Organization. Assessment of the child with cough or difficult breathing [ J ]. In : WHO/ARI/90.5. Geneva: World Health Organization, 1990.5.
10British Thoracic Society Standards of Care Committee. BTS Guideline for the management of community pneumonia in childhood [ J ]. Thorax,2002,57 (suppl 1): 11.
4Cammarota G, Cianci R, Cannizzaro O, et al, High-dose versus low-doseclarithromycin in l-wcck triple therapy, in-cluding rabe- prazole and levofloxacin, for HelicobaeterPylori eradication. J Clin Gastroenterol, 2004,38(2):110- 114.
5Wong BC. Lain SK,Wong WM, et al. Helicobacter pylori eradica- tion to prevent gastric cancer in a high-risk region of Chink a ran- domized controlled trial. JAMA,2004,291(2) : 187-194.
